FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4220745692> ?p ?o ?g. }

• W4220745692 endingPage "e0262831" @default.
• W4220745692 startingPage "e0262831" @default.
• W4220745692 abstract "Patients with type 2 diabetes who have cardiovascular disease and are receiving empagliflozin have a lower rate of primary composite cardiovascular outcomes. In contrast, glimepiride increases cardiovascular hospitalization when combined with metformin. Here, we assessed the effects of empagliflozin and glimepiride on endothelial function using flow-mediated dilation (FMD). In this prospective, open-label, randomized, parallel-group study, 63 patients with type 2 diabetes received metformin and insulin glargine U100 for 12 weeks. This was followed by additional treatment with empagliflozin or glimepiride for 12 weeks. The primary outcome was the change in the FMD measurement (ΔFMDs) at 24 weeks of additional treatment. Secondary outcomes comprised changes in metabolic markers and body composition. The empagliflozin group (n = 33) and glimepiride group (n = 30) showed no significant differences in ΔFMDs (empagliflozin, -0.11 [95%CI: -1.02, 0.80]%; glimepiride, -0.34 [95%CI: -1.28, 0.60]%; P = 0.73). Additionally, changes in glycated hemoglobin were similar between the two groups. However, a significant difference in body weight change was observed (empagliflozin, -0.58 [95%CI: -1.60, 0.43] kg; glimepiride, 1.20 [95%CI: 0.15, 2.26] kg; P = 0.02). Moreover, a body composition analysis revealed that body fluid volume significantly decreased after empagliflozin treatment (baseline, 35.8 ± 6.8 L; after 12 weeks, -0.33 ± 0.72 L; P = 0.03). Hence, although empagliflozin did not improve endothelial function compared with glimepiride for patients with type 2 diabetes, it did decrease body fluid volumes. Thus, the coronary-protective effect of empagliflozin is not derived from endothelial function protection, but rather from heart failure risk reduction. Trial registration: This trial was registered on September 13, 2016; UMIN000024001." @default.
• W4220745692 created "2022-04-03" @default.
• W4220745692 creator A5024648292 @default.
• W4220745692 creator A5057132504 @default.
• W4220745692 creator A5059444576 @default.
• W4220745692 creator A5060246940 @default.
• W4220745692 creator A5074653761 @default.
• W4220745692 creator A5088387334 @default.
• W4220745692 date "2022-02-16" @default.
• W4220745692 modified "2023-09-25" @default.
• W4220745692 title "Comparison of the effects of empagliflozin and glimepiride on endothelial function in patients with type 2 diabetes: A randomized controlled study" @default.
• W4220745692 cites W1555489744 @default.
• W4220745692 cites W1849785625 @default.
• W4220745692 cites W1866762244 @default.
• W4220745692 cites W1904336231 @default.
• W4220745692 cites W1965568218 @default.
• W4220745692 cites W1996385661 @default.
• W4220745692 cites W2027545319 @default.
• W4220745692 cites W2048875545 @default.
• W4220745692 cites W2057116025 @default.
• W4220745692 cites W2064130493 @default.
• W4220745692 cites W2080167189 @default.
• W4220745692 cites W2087584088 @default.
• W4220745692 cites W2091836518 @default.
• W4220745692 cites W2095784604 @default.
• W4220745692 cites W2099637593 @default.
• W4220745692 cites W2101374656 @default.
• W4220745692 cites W2114481251 @default.
• W4220745692 cites W2122880159 @default.
• W4220745692 cites W2126068905 @default.
• W4220745692 cites W2133071972 @default.
• W4220745692 cites W2142830692 @default.
• W4220745692 cites W2143968950 @default.
• W4220745692 cites W2144295528 @default.
• W4220745692 cites W2146264128 @default.
• W4220745692 cites W2150392479 @default.
• W4220745692 cites W2157966156 @default.
• W4220745692 cites W2167147898 @default.
• W4220745692 cites W2171471305 @default.
• W4220745692 cites W2202866687 @default.
• W4220745692 cites W2273304042 @default.
• W4220745692 cites W2302447233 @default.
• W4220745692 cites W2424539745 @default.
• W4220745692 cites W2425644022 @default.
• W4220745692 cites W2529195837 @default.
• W4220745692 cites W2535774208 @default.
• W4220745692 cites W2763866789 @default.
• W4220745692 cites W2782989965 @default.
• W4220745692 cites W2899764361 @default.
• W4220745692 cites W2900413769 @default.
• W4220745692 cites W2902485108 @default.
• W4220745692 cites W2939222610 @default.
• W4220745692 cites W4211214771 @default.
• W4220745692 doi "https://doi.org/10.1371/journal.pone.0262831" @default.
• W4220745692 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35171918" @default.
• W4220745692 hasPublicationYear "2022" @default.
• W4220745692 type Work @default.
• W4220745692 citedByCount "4" @default.
• W4220745692 countsByYear W42207456922022 @default.
• W4220745692 countsByYear W42207456922023 @default.
• W4220745692 crossrefType "journal-article" @default.
• W4220745692 hasAuthorship W4220745692A5024648292 @default.
• W4220745692 hasAuthorship W4220745692A5057132504 @default.
• W4220745692 hasAuthorship W4220745692A5059444576 @default.
• W4220745692 hasAuthorship W4220745692A5060246940 @default.
• W4220745692 hasAuthorship W4220745692A5074653761 @default.
• W4220745692 hasAuthorship W4220745692A5088387334 @default.
• W4220745692 hasBestOaLocation W42207456921 @default.
• W4220745692 hasConcept C126322002 @default.
• W4220745692 hasConcept C134018914 @default.
• W4220745692 hasConcept C2775887513 @default.
• W4220745692 hasConcept C2776307423 @default.
• W4220745692 hasConcept C2777180221 @default.
• W4220745692 hasConcept C2780323712 @default.
• W4220745692 hasConcept C555293320 @default.
• W4220745692 hasConcept C71924100 @default.
• W4220745692 hasConceptScore W4220745692C126322002 @default.
• W4220745692 hasConceptScore W4220745692C134018914 @default.
• W4220745692 hasConceptScore W4220745692C2775887513 @default.
• W4220745692 hasConceptScore W4220745692C2776307423 @default.
• W4220745692 hasConceptScore W4220745692C2777180221 @default.
• W4220745692 hasConceptScore W4220745692C2780323712 @default.
• W4220745692 hasConceptScore W4220745692C555293320 @default.
• W4220745692 hasConceptScore W4220745692C71924100 @default.
• W4220745692 hasIssue "2" @default.
• W4220745692 hasLocation W42207456921 @default.
• W4220745692 hasLocation W42207456922 @default.
• W4220745692 hasLocation W42207456923 @default.
• W4220745692 hasLocation W42207456924 @default.
• W4220745692 hasLocation W42207456925 @default.
• W4220745692 hasOpenAccess W4220745692 @default.
• W4220745692 hasPrimaryLocation W42207456921 @default.
• W4220745692 hasRelatedWork W1986052847 @default.
• W4220745692 hasRelatedWork W1996036642 @default.
• W4220745692 hasRelatedWork W2005084305 @default.
• W4220745692 hasRelatedWork W2033313326 @default.
• W4220745692 hasRelatedWork W2052503411 @default.
• W4220745692 hasRelatedWork W2744240433 @default.

• next